Pike + Zijlmans provides Imanova Limited with fixed asset appraisal relating to the acquisition by Invicro LLC

Pike + Zijlmans provides Imanova Limited with fixed asset appraisal relating to the acquisition by Invicro LLC

Imagine a vacuum chamber containing particles whizzing around, accelerating, and colliding. These particles, influenced by an electromagnet, become highly charged with energy and can be used to create images and track drug therapies within the human body. This modern marvel is a cyclotron, a standard but complex piece of machinery used to create the radiotracers for medical imaging and just one of the assets that Pike + Zijlmans valued for their client, Imanova Limited.

Invicro LLC acquired Imanova Limited in September 2017 with plans to continue to make advancements in translational medicine and the use of imaging in drug discovery and development.  When one company acquires another, accounting regulations require a process called Purchase Price Allocation (PPA).  Key results from the PPA are included in the acquiror’s financial statements.  Pike + Zijlmans was requested to provide fixed asset valuations.  Projects of this magnitude typically require one month to complete, however the client’s timeframes were limited to one week. Pike + Zijlmans was able to meet the client’s time requirements because of their industry knowledge.

Pike + Zijlmans strives to work at the forefront of their field.  We are dedicated to providing business valuations and fixed asset appraisals for clients in a diverse span of industries, including medicine and technology.

For more information regarding fixed asset appraisals, purchase price allocations, or other services provided by Pike + Zijlmans, do not hesitate to contact Pieter Zijlmans at pzijlmans@pikezijlmans.com or at +31 20 261 6460.

 

About Pike + Zijlmans

Clients around the world trust Pike + Zijlmans for business valuation and fixed asset appraisal services. We help stakeholders in a broad range of industries with company valuations ranging from micro-cap to large-cap. Our solutions are state-of-the-art, knowledge-rich, and practical.